Decreased clinical response to adalimumab in ankylosing spondylitis is associated with antibody formation

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Annals of the rheumatic diseases 2009-11, Vol.68 (11), p.1787-1788
Hauptverfasser:	de Vries, M K, Brouwer, E, van der Horst-Bruinsma, I E, Spoorenberg, A, van Denderen, J C, Jamnitski, A, Nurmohamed, M T, Dijkmans, B A C, Aarden, L A, Wolbink, G J
Format:	Artikel
Sprache:	eng
Schlagworte:	Adalimumab Adult Antibodies, Anti-Idiotypic - biosynthesis Antibodies, Monoclonal - immunology Antibodies, Monoclonal - therapeutic use Antibodies, Monoclonal, Humanized Antirheumatic Agents - immunology Antirheumatic Agents - therapeutic use Biological and medical sciences Diseases of the osteoarticular system Diseases of the spine Drug Tolerance Female Humans Immunomodulators Inflammatory joint diseases Male Medical sciences Middle Aged Pharmacology. Drug treatments Spondylitis, Ankylosing - drug therapy Spondylitis, Ankylosing - immunology Tumor Necrosis Factor-alpha - antagonists & inhibitors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!